Article
Author(s):
San Francisco - The FDA has its eye on New-Fill (Dermik Laboratories), a polylactic acid filler that experts predict could become a popular treatment for moderate to deep wrinkles and volume loss.
The Weekly Roundup: December 16-20
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Dermatology Times December 2024 Recap
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
How OJM Group Can Help Dermatologists Reach Their Financial Goals in 2025 and Beyond
Interview Intersection: Expert Interviews From December 2024